The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

Results from the largest and longest study of its kind have found that the drug metformin can help manage weight gain in ...

Millions of Americans with anxiety and depression struggle to find the right medication. The best fit may depend on your ...

Following a WESH 2 Investigates exclusive report on the death of a man behind bars at the Osceola County Jail, the man’s ...

The new approval is the first for the drug under JNJ leadership. ・The drug is also approved for the treatment of bipolar I and II depression as well as schizophrenia in adults. ・JNJ recently submitted ...

Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person's sense of reality.

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...

The final, formatted version of the article will be published soon. Abstract Objective: Persistent Genital Arousal Disorder (PGAD) is a rare and distressing condition characterized by persistent ...

Gucci Mane is sharing his experience after being diagnosed with bipolar disorder and schizophrenia. In his book “Episodes: The Diary of a Recovering Mad Man,” the 45-year-old rapper reveals the ...